ETIntelligence Group - Pharma Reports

Research Channels
- India Economy
  - News
  - Reports
- Global Economy
  - News
  - Reports
- Sectors
  - Auto
    - News
    - Reports
  - Auto Ancillary
    - News
    - Reports
  - Banking
    - News
    - Reports
  - Capital Goods
    - News
    - Reports
  - Cement
    - News
    - Reports
  - Consumer Durables
    - News
    - Reports
  - Construction
    - News
    - Reports
  - Defence
    - News
    - Reports
  - Electricity
    - News
    - Reports
  - Fertilizers
    - News
    - Reports
  - FMCG
    - News
    - Reports
  - IT
    - News
    - Reports
  - Media & Entertainment
    - News
    - Reports
    - ETIG Multiplex Tracker
  - Mines & Minerals
    - News
    - Reports
  - NBFC
    - News
    - Reports
  - Oil & Gas
    - News
    - Reports
  - Pharma
    - News
    - Reports
  - Retail & E-Commerce
    - News
    - Reports
  - Steel
    - News
    - Reports
  - Sugar
    - News
    - Reports
  - Telecom
    - News
    - Reports
  - Textiles
    - News
    - Reports
  - Tourism
    - News
    - Reports
  - Tyre
    - News
    - Reports
- Markets
  - Equity Market
  - Derivatives
  - Money & Bond
    - News
    - Reports
  - Real Estate
  - Mutual Funds
    - News
    - Reports
    - Data
  - IPO
  - Sectoral Portfolio Tracker
- Company Research Reports
- ET Interview
- Insurance
- Tax
- NCLT
- Mergers & Acquisition
  - Deal News
  - Reports
- Supply Chain Mgmt
  - News
  - Reports
- Political News
- Columns
  - Columns Archive
  - Expert Take
- ET Classroom
- Budget
- ET Collectibles
Market Moksha
ETIG OneView
ETIndices
ET500
Commodity 360⁰

Reports Archive

Consumer Durables

Media & Entertainment

Mines & Minerals

Retail & E-Commerce

Reports Archive

Year

Date	Title	Pages	Source	Download

Apr-25	4QFY25 Preview: Focus on Domestic Plus Margin Variance	9	Emkay Research

Apr-25	HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Pharma dodges first round of US tariff risk	8	HDFC Securities

Jan-25	March of corporate hospitals: Deepening presence	143	Emkay Research

Jan-25	US pricing pressure eases; margins improve	5	Nirmal Bang

Jan-25	Chemicals/Pharma EXIM trends	20	Phillip Capital

Jan-25	3QFY25 Preview: Change in script unlikely	7	Emkay Research

Jan-25	Bed additions/ARPOB to drive growth during the quarter	7	Centrum Research

Jan-25	US/India to drive Pharma; Volume-led growth to continue for Diagnostics	8	Centrum Research

Jan-25	Q3FY25 Preview: Seasonal benefits add to momentum	6	Phillip Capital